Microvascular autoregulation in children and adolescents with type 1 diabetes mellitus

O Schlager1, A Hammer, A Willfort-Ehringer

  • 1Department of Medicine II, Division of Angiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

Diabetologia
|February 28, 2012
PubMed

Insights

Postocclusive reactive hyperaemia (PORH) testing reveals impaired microvascular autoregulation in children with type 1 diabetes. This suggests potential early changes in blood vessel function in young patients with diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Vascular Physiology
  • Diabetes Research

Background:

  • Microvascular dysfunction is an early complication of type 1 diabetes mellitus.
  • Assessing microvascular autoregulation in children with type 1 diabetes is crucial for understanding disease progression.

Purpose of the Study:

  • To investigate if microvascular autoregulation is impaired in children with type 1 diabetes.
  • To determine if postocclusive reactive hyperaemia (PORH) can non-invasively detect these impairments.

Main Methods:

  • Assessed microvascular autoregulation using PORH with laser Doppler fluxmetry in 58 children with type 1 diabetes and 58 healthy controls.
  • Measured baseline perfusion, biological zero, peak perfusion, time to peak, and recovery time.

Main Results:

  • Children with type 1 diabetes exhibited higher peak perfusion (1.7 ± 0.93 AU vs 1.29 ± 0.46 AU; p = 0.004) and lower biological zero (0.14 ± 0.04 AU vs 0.19 ± 0.04 AU; p < 0.0001) compared to controls.
  • No significant differences were found in baseline perfusion, time to peak, or recovery time.

Conclusions:

  • PORH effectively identifies impaired microvascular autoregulation in children with type 1 diabetes.
  • Elevated peak perfusion may indicate reduced vasoconstrictive capacity in arteriolar smooth muscle cells in this population.
Abstract

Related Concept Videos

Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...